The Lancet Neurology in conversation with
This podcast delves into the latest breakthroughs in brain health and neurological disease through conversations with leading researchers, neurologists, and policy experts. Each episode simplifies complex topics for a general audience, translating advanced science into actionable insights. The editors of The Lancet Neurology interview experts working on stroke, Alzheimer's disease, epilepsy, migraine, Parkinson's disease, multiple sclerosis, sleep disorders, traumatic brain injury, and other neurological challenges.
Episodes
The future of Alzheimer’s disease: blood biomarkers, brain imaging, and screening the cognitively unimpaired
What will Alzheimer’s disease diagnosis look like in 5–10 years?
In this episode of In Conversation With…, Laura Hart is joined by the authors behind The Lancet Neurology Series on Future Directions in Alzheimer’s Disease and Related Disorders: Clifford Jack (Mayo Clinic), Charlotte Teunissen (Amsterdam UMC), Tammie Benzinger (Washington University in St Louis), and Jonathan Graff-Radford (Mayo Cl
Marjo van der Knaap on vanishing white matter
For decades, a diagnosis of vanishing white matter disease came with no real treatment — so how is an old blood-pressure pill offering hope? In this episode of In Conversation With…The Lancet Neurology, Deputy Editor Laura Hart speaks with Professor Marjo van der Knaap (Amsterdam UMC) about her clinical trial of guanabenz in children with the leukodystrophy vanishing white matter. They unpack the
Jan D Lünemann and Christian Münz on Epstein–Barr virus and multiple sclerosis
In this episode, Heather Brown, Senior Editor at The Lancet Neurology, chats with Jan Lünemann (University of British Columbia, Canada) and Christian Münz (University of Zürich, Switzerland) about their Rapid Review on Epstein-Barr virus (EBV) and multiple sclerosis (MS).
EBV, a common herpesvirus, has been strongly implicated in development of MS, and recent mechanistic advances are providing n
Hal Dietz discusses the role of genetics in spinal CSF leaks
In this episode of In Conversation With, Morgane Boillot, Senior Editor at The Lancet Neurology, speaks with connective tissue disorders — including Marfan syndrome — and human genetics expert Hal Dietz from Johns Hopkins Medicine (Baltimore, USA) about the genetics of spontaneous spinal CSF leaks.
Together, they explore the clinical presentation, diagnosis, and current treatment of spontaneous sp
Tony Schapira on GBA1 Parkinson's disease
In this episode of In Conversation With, Elena Becker-Barroso, Editor-in-Chief of The Lancet Neurology, speaks with movement disorders specialist Tony Schapira from UCL’s Queen Square Institute of Neurology about GBA1-associated Parkinson’s disease.
Together, they explore the genetic, clinical, and biochemical links between GBA1 variants, lysosomal function, Gaucher disease, alpha-synuclein pathol
Henry Brodaty and Alice Powell on cognitive resilience and ageing
Join The Lancet Neurology’s In Conversation With… as editors Elena Becker-Barroso and Laura Hart welcome Henry Brodaty and Alice Powell from the University of New South Wales (Sydney, Australia) to discuss cognitive resilience and ageing.
This episode teases apart cognitive resilience, cognitive reserve, brain maintenance, and brain reserve; explores how social determinants, life-course factors, a
Niklas Mattsson-Carlgren on the use of biomarkers in the diagnosis and stratification of Alzheimer’s disease
In this episode, Laura Hart and Elena Becker-Barroso speak with Niklas Mattsson-Carlgren (Lund University) about the use of blood biomarkers in the diagnosis and stratification of Alzheimer's disease. They discuss two particular plasma biomarkers—p-tau217 and eMTBR-tau243—including what they measure and how a proposed practical two-step approach that uses p-tau217 as an initial screen in a neurolo
Cristina Tassorelli on migraine prevention
In this episode, Senior Editor Morgane Boillot speaks with Professor Cristina Tassorelli (University of Pavia, Italy) about recent advances in migraine prevention.
Together with colleagues, Tassorelli has authored a Review in the journal examining the major developments in migraine-specific pharmacological treatments over the past decade, with a particular focus on therapies targeting the CGRP pa
Inga Zerr and Simon Mead on advances in prion diseases
Our Editor-in-Chief, Elena Becker-Barroso, speaks with Inga Zerr (DZNE, Göttingen, Germany) and Simon Mead (UCL London, UK) about the latest advances in prion diseases.
In collaboration with other experts, Zerr and Mead have authored a Series in the journal that covers the genetic factors behind these diseases, and new diagnostic and prognostic biomarkers.
Click here to read the full articles:
ht
Julia Greenland on azathioprine for early Parkinson’s disease
Host Morgane Boillot chats with Dr Julia Greenland about a clinical trial of azathioprine in early Parkinson's disease.
Click here to read the full article: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00386-2/fulltext
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announc
Ian McKeith on dementia with dementia with Lewy bodies
In this episode, host Antonia Eisenkoeck, speaks with Ian McKeith, Emeritus Professor of Old Age Psychiatry at Newcastle University, UK. They delve into the history of dementia with Lewy bodies research, highlighting key milestones and breakthroughs. Discover insights into the current state of the field and what the future holds for understanding and treating this condition.
Click here to read the
Ask Nordestgaard on long-term stroke risk in women
In this episode, host Laura Hart chats with Ask Nordestgaard (Brigham and Women's Hospital, Boston, USA) about the long-term risk of stroke in healthy women, the role of inflammation and lipoproteins, and how early biomarker screening could transform stroke prevention strategies.
Click here to read the full article.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and u
Shiv Saidha on recent updates in the diagnosis of multiple sclerosis
Morgane Boillot chats with Professor Shiv Saidha (Johns Hopkins University, USA) about recent developments in diagnosing multiple sclerosis, and specifically on the use of paraclinical tests of the optic nerve in this context.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00270-4/fulltext?dgcid=buzzsprout_icw_podcast_September_25_laneur
Medical imaging a
Michael Rafii on Down syndrome-related Alzheimer’s disease
People with Down syndrome face a high risk of developing Alzheimer’s disease, which is the leading cause of death in this population over the age of 35.
In this episode, Morgane Boillot (Senior Editor) is joined by Professor Michael Rafii to explore the intersection of Down syndrome and Alzheimer’s disease. They discuss the latest research into disease pathology, biomarkers, and clinical trials,
Amit Bar-Or on fenebrutinib for relapsing multiple sclerosis
In this episode, host Laura Hart chats with Professor Amit Bar-Or (University of Pennsylvania) about the potential of the BTK inhibitor fenebrutinib in treating relapsing multiple sclerosis, highlighting future challenges in MS research.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00174-7/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laneur
Medical ima
Marte-Helene Bjørk on reproductive risks in people with epilepsy
Sarah Passey is joined by Dr Marte-Helene Bjørk (Haukeland University Hospital, Norway) to discuss the latest evidence and practical guidance on managing reproductive risks in people with epilepsy, including medication safety, pregnancy planning, and global challenges in care.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00130-9/fulltext?dgcid=buzzsprou
Geoff Manley on a new classification system for traumatic brain injury
Assistant Editor Sam Griffiths is joined by Professor Geoff Manley (UCSF, CA, USA) to discuss his new NIH-NINDS classification of acute TBI, the limitations of traditional classifications, how the new framework was developed, and what it means for the future of TBI research and patient care.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00154-1/fulltext?
Wayne Feng on stroke rehabilitation using brain stimulation and constraint-induced movement therapy
Increasing numbers of people are surviving stroke but with motor impairments that can contribute substantially to long-term disability.
Transcranial direct current stimulation has shown promise in reducing motor impairment when combined with rehabilitation therapy. Sarah Passey talks to Wayne Feng (Duke University School of Medicine, Durham, NC, USA) about his latest trial, TRANSPORT2, which asse
Marialuisa Gandolfi on the management of chronic pain in Parkinson’s disease
In this podcast, linked to the April 2025 issue of The Lancet Neurology, Laura Hart (Deputy Editor) chats to Marialuisa Gandolfi (University of Verona in Italy) about advances in the classification and management of pain in Parkinson’s disease.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to anno
Michael Tymianski on neuroprotection in stroke
Sarah Passey (The Lancet Neurology) is joined by Michael Tymianski (University Health Network, Toronto, Canada) to discuss an Article in the March issue reporting a meta-analysis looking at neuroprotection in stroke and what can be learnt for future research.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PiiS1474-4422(24)00515-5/fulltext?dgcid=buzzsprout_icw_podcast_gene
Elizabeth Finger on oxytocin for apathy in frontotemporal dementia
In this podcast, linked to the February 2025 issue of The Lancet Neurology, Elena Becker-Barroso (Editor-in-Chief) chats to Elizabeth Finger (Western University, London, ON, Canada) about the FOXY trial of oxytocin for apathy in people with frontotemporal dementia.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00456-3/fulltext?dgcid=buzzsprout_icw_podca
The Lancet Neurology Editors on advances in neurology in 2024
The Lancet Neurology Editors take a look back at advances in neurology in 2024, as highlighted by experts in a series of Round-ups published in the January issue.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch of, The Lancet Medical Imaging and Theranostics.
You can visit ht
Florian Krismer and Elizabeth Coon on multiple system atrophy
Florian Krismer (Innsbruck Medical University) and Elizabeth Coon (Mayo Clinic) join Sarah Passey (The Lancet Neurology) to discuss their Review paper on multiple system atrophy, which is published in the December issue of The Lancet Neurology.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to anno
Suvankar Pal on the motor neuron disease trial MND-SMART
Professor Suvankar Pal (University of Edinburgh) joins Sarah Passey (Senior Editor at The Lancet Neurology) to discuss the first findings from the MND-SMART trial of treatments for motor neuron disease. The Article is published in the November issue of The Lancet Neurology.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The
Jorge Correale and Lilyana Amezcua on differential diagnosis of multiple sclerosis
Prof Jorge Correale and Dr Lilyana Amezcua talk to The Lancet Neurology about their Personal View papers, published in the October 2024 issue, on the differential diagnosis of multiple sclerosis in regions outside North America and Western Europe and in people from minority ethnic or racial backgrounds in North America, northern Europe, and Australasia.
Read the full article:
https://www.thelance
Alex Iranzo on sleep and Parkinson’s disease
Dr Alex Iranzo joins The Lancet Neurology to discuss his recent Review on the association between sleep disorders and Parkinson's disease. The Review is published in the August issue of The Lancet Neurology.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00170-4?dgcid=buzzsprout_icw_podcast_generic_laneur
Medical imaging and theranostics are revolutionis
Adrian Owen on detecting awareness after acute brain injury
Dr Adrian Owen joins Sarah Passey to chat about a his Personal View, published in the August 2024 issue of The Lancet Neurology, about detecting awareness after an acute brain injury.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch of, The Lancet Medical Imaging and Theranosti
Glenn Nielsen on specialist physiotherapy for people with functional motor disorder
Dr Glenn Nielsen joins Lauren Southwell to discuss the Physio4FMD trial of specialist physiotherapy for people with functional motor disorder in England and Scotland. This Article is published in the July issue of The Lancet Neurology.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the
Sanjay Sisodiya on climate change and brain health
Sanjay Sisodiya joins The Lancet Neurology to discuss the potential effects of climate change on brain health. The Personal View is published in the June issue of The Lancet Neurology.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch of, The Lancet Medical Imaging and Theranost
Jacqueline French and Jacob Pellinen on the diagnosis of epilepsy
Jacqueline French and Jacob Pellinen join Senior Editor Sarah Passey to discuss recent progress made in the diagnosis of epilepsy and challenges that remain. Their Review on this topic is published in the May issue of The Lancet Neurology.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00079-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_laneur
Medical
Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua on the global burden of disorders affecting the nervous system
Jaimie Steinmetz and Theo Vos from the Institute for Health Metrics and Evaluation, and Katrin Seeher and Tarun Dua from WHO, join Heather Brown and Lauren Southwell to discuss new data on the global, regional, and national burden of disorders affecting the nervous system. The Article is published in the April issue of The Lancet Neurology.
Medical imaging and theranostics are revolutionising how
Giovanni Frisoni on biomarker-based diagnosis of neurocognitive disorders
Giovanni Frisoni joins The Lancet Neurology to discuss new European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders. The Personal View is published in the March issue of The Lancet Neurology.
Read the full article:
https://www.thelancet.com/journals/laneur/article/S1474-4422(23)00447-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_laneur
Medical imaging
Marianne Chapleau and Gil Rabinovici on posterior cortical atrophy
Marianne Chapleau and Gil Rabinovici join Senior Editor Sarah Passey to discuss their research on posterior cortical atrophy. The Article is published in the February issue of The Lancet Neurology.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00414-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_laneur
Medical imaging and theranostics are revolutionisi
Cecilia Åkerlund and David Nelson on prognosis of traumatic brain injury
Cecilia Åkerlund and David Nelson join The Lancet Neurology to discuss their research on clinical variables that might distinguish how the disease process progresses in people with traumatic brain injury. The Article is published in the January issue of The Lancet Neurology.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00358-7/fulltext?dgcid=buzzsprout
Rustam Al-Shahi Salman on the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage
Rustam Al-Shahi Salman joins Senior Editor Sarah Passey to discuss the COCROACH meta-analysis findings, published in the December issue of The Lancet Neurology, of the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00315-0/fulltext?dgcid=buzzspr
Njideka Okubadejo and Mie Rizig on Parkinson’s disease in African and African admixed populations
Njideka Okubadejo and Mie Rizig join The Lancet Neurology to discuss their comprehensive genome-wide assessment in African and African admixed individuals with the aim of developing a better understanding of the genetic architecture of Parkinson's disease in these underserved populations.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00283-1/fulltext?dg
Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis
Anthony Feinstein (University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Canada) discusses CogEx, a randomised trial of cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis. The Article is published in the October issue of The Lancet Neurology.
Medical imaging and theranostics are revolutionising how we diagnose, treat
William Jagust on amyloid β and cognition
William Jagust (University of California in Berkeley, CA, USA) talks to Senior Editor Sarah Passey about the complex pathway between amyloid β and cognition, and implications for therapy for people with Alzheimer’s disease. His Personal View on this topic is published in the September issue of The Lancet Neurology.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-
Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury
Stephen Strittmatter (Yale School of Medicine, CT, USA) discusses his first-in-human and randomised trial of a soluble Nogo-receptor-Fc decoy in patients with chronic cervical spinal cord injury. The Article is published in the August issue of The Lancet Neurology.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00215-6/fulltext?dgcid=buzzsprout_icw_podca
Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases
Benzi Kluger (University of Rochester Medical Center, Rochester, NY, USA), Claire Creutzfeldt (University of Washington, Seattle, WA, USA), and Malenna Sumrall (University of Colorado Anschutz Medical Campus, Aurora, CO, USA) join Jonathan Blott to discuss palliative care for individuals with neurological diseases, exploring the challenges and opportunities in enhancing the quality of life for tho
Andrew Cole on the complexities underlying epilepsy in people with glioblastoma
Andrew Cole (Massachusetts General Hospital Epilepsy Service, Boston, MA, USA) talks to Senior Editor Sarah Passey about the complexities underlying epilepsy in people with glioblastoma. His Review on this topic is published in the June issue of The Lancet Neurology.
Read the full article here: thelancet.com/journals/laneur/article/PIIS1474-4422(23)00031-5/fulltext?dgcid=buzzsprout_icw_podcast_la
Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation
Karen Duff and Connor Langworth-Green (University College London, London, UK) discuss tauopathies and the chronic effects of inflammation on this group of disorders. Their Personal View on this topic is published in the May issue of The Lancet Neurology.
Read the Personal View here:
Chronic effects of inflammation on tauopathies
Medical imaging and theranostics are revolutionising how we diagnose
Kerstin Hellwig on family planning considerations in MS
Kerstin Hellwig (Ruhr University Bochum, Bochum, Germany) discusses family planning considerations in multiple sclerosis. This Review is published in the April issue of The Lancet Neurology.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch of, The Lancet Medical Imaging and The
Geraldine Dawson on advances in the prediction of autism during infancy
Geraldine Dawson (Duke University School of Medicine, NC, USA ) discusses the latest advances and ongoing challenges in prediction of autism during infancy. This Review is published in the March issue of The Lancet Neurology.
Read the full article:
Prediction of autism in infants: progress and challenges
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand d
Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke
Ellisiv Mathiesen (The University of Tromsø – the Arctic University of Norway, Tromsø, Norway) discusses the findings of the TWIST trial, which investigated the use of tenecteplase for patients with wake-up stroke who were selected for treatment by non-contrast CT. This Fast-track Article is published in the February issue of The Lancet Neurology.
Read the full article:
Safety and efficacy of ten
Beau Ances on amyloid biomarkers in Alzheimer’s
Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology.
Read the full article:
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease
Medical imaging and theranostics are re
Axel Petzold on the diagnosis and classification of optic neuritis
Axel Petzold (National Hospital for Neurology and Neurosurgery and Moorfields Eye Hospital, London, UK, and Amsterdam University Medical Center, Amsterdam, Netherlands) discusses a Position Paper, published in the December issue of The Lancet Neurology, which sets out new criteria for the diagnosis and classification of optic neuritis.
Read the Position Paper:
Diagnosis and classification of opti
Maeike Zijlmans on using biomarkers to tailor epilepsy surgery
Maeike Zijlmans (University Medical Center Utrecht, Utrecht, Netherlands) discusses recent research on tailoring of epilepsy surgery with biomarkers on intraoperative electrocorticography, and describes some of the challenges of this technique and what the future steps are for the field; the Article is published in the November issue of The Lancet Neurology.
Medical imaging and theranostics are
Jerome Siegel on sleep habits
Jerome Siegel (University of California, Los Angeles, CA, USA) discusses sleep research in hunter-gatherer populations and what we can learn from the sleep habits of various species; his Review is published in the October issue of The Lancet Neurology, which is the fourth paper in The Lancet’s Series on sleep and sleep disorders.
Medical imaging and theranostics are revolutionising how we diagnos
Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy
Laurent Servais and Dora Markati (both from the University of Oxford, UK) discuss emerging therapies for Duchenne muscular dystrophy; their Review is published in the September issue of The Lancet Neurology.
Read the full Review:
Emerging therapies for Duchenne muscular dystrophy
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this mom
Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy
Andreas Charidimou (Massachusetts General Hospital, Boston, MA, USA) discusses an international collaborative study that presents new Boston criteria for diagnosis of cerebral amyloid angiopathy; the Article is published in the August issue of The Lancet Neurology.
Read the full article:
The Boston criteria version 2.0 for cerebral amyloid angiopathy
Medical imaging and theranostics are revoluti
Sarah Tabrizi and Cristina Sampaio on classifying Huntington’s and new therapies
Sarah Tabrizi (UCL Queen Square Institute of Neurology, London, UK) and Cristina Sampaio (CHDI Foundation, Princeton, NJ, USA) discuss two papers on Huntington’s disease published in the July issue of The Lancet Neurology: a Position Paper outlining a new classification of the disease, called the Huntington’s Disease Integrated Staging System, and a Personal View on potential disease-modifying the
Mark Hallett on functional neurological disorder
Mark Hallett (National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA) discusses his Review, published in the June issue of The Lancet Neurology, on functional neurological disorder, and talks about new subtypes of this disorder, diagnostic challenges, and how education is important.
Read the full article:
Functional neurological disorder: new subtypes and shared mechanisms
Med
Eva Feldman on advances in understanding ALS
Eva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic development, and the diagnosis and prognosis of amyotrophic lateral sclerosis; the Series is published in the May issue of The Lancet Neurology.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet thi
Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer’s
Estrella Morenas-Rodriguez and Christian Haass (German Centre for Neurodegenerative Diseases, Munich, Germany) discuss their recent research, published in the April issue of The Lancet Neurology, on soluble TREM2 and its association with Alzheimer’s disease biomarkers and cognition.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this mo
John Collinge on a treatment for CJD
John Collinge (MRC Prion Unit, University College London, London, UK) discusses a first-in-human treatment programme to give PRN100, an anti-prion-protein monoclonal antibody, to patients with Creutzfeldt–Jakob disease; the report is published in the April issue of The Lancet Neurology.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet thi
Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2
Alexandra Durr (Paris Brain Institute, Pitié-Salpêtrière Paris, France) discusses the ATRIL study, a randomised trial of riluzole in patients with spinocerebellar ataxia type 2, which is published in the March issue of The Lancet Neurology.
Read the full article:
Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL)
Medical imaging and theranostics are revolutionising
Giuseppe Citerio on frailty and TBI
Giuseppe Citerio (University of Milano-Bicocca, Milan, Italy) discusses the implications of a study from the CENTER-TBI project of the effect of frailty on 6-month outcome after traumatic brain injury, which is published in the February issue of The Lancet Neurology.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lance
Alberto Costa on memantine in adolescents and young adults with Down syndrome
Alberto Costa (Case Western Reserve University, Cleveland, OH, USA) discusses his study on the use of memantine in adolescents and young adults with Down syndrome, which is published in the January issue of The Lancet Neurology.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00369-0/fulltext
Medical imaging and theranostics are revolutionising how we dia
Olivier Rascol on amantadine for patients with movement disorders
Olivier Rascol (Toulouse University, France) discusses the uses of amantadine in the treatment of patients with movement disorders, which are the focus of his Personal View in the December issue of The Lancet Neurology.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00249-0/fulltext
Medical imaging and theranostics are revolutionising how we diagnose, tr
Antonio Uccelli on stems cells for MS
Antonio Uccelli (University of Genoa) discusses his research, published in the November issue of The Lancet Neurology, on the therapeutic use of mesenchymal stem cells for multiple sclerosis.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00301-X/fulltext
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease.
Priya Palta on blood pressure control and cognitive decline
Priya Palta (Columbia University, New York) explains the importance of blood pressure control in the prevention of cognitive decline. Her Review, published in the October issue of The Lancet Neurology, provides an update of the mounting evidence that links hypertension with dementia risk.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00248-9/fulltext
Me
Adam Boxer on tau biomarkers
Adam Boxer (University of California, San Francisco) discusses his research, published in August issue of The Lancet Neurology, on diagnostic performance of tau biomarkers in neurodegenerative diseases.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00214-3/fulltext
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understa
Irene Cortese on the difficulties of designing clinical trials
Irene Cortese (National Institute of Neurological Disorders and Stroke) discusses the difficulties of designing clinical trials in progressive multifocal leukoencephalopathy and talks about a pilot study of virus-specific T cells for treatment of this population, published in the August issue of The Lancet Neurology.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS147
Doug Turnbull on mitochondrial diseases in adults
Doug Turnbull (University of Newcastle) discusses mitochondrial diseases in adults, which are reviewed in the July issue of The Lancet Neurology, and explains how important these diseases are for neurologists.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00098-3/fulltext
Medical imaging and theranostics are revolutionising how we diagnose, treat, and u
Geert Jan Biessels on predicting post-stroke cognitive impairment
Geert Jan Biessels (University Medical Centre Utrecht) discusses his research, published in our June issue, on using strategic infarct locations to predict post-stroke cognitive impairment.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00060-0/fulltext
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. T
Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALS
Henk-Jan Westeneng discusses his new work on the causal effects of pre-symptomatic lifestyle on ALS.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00042-9/fulltext
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch of, The Lancet Medi
Anne MacGregor on menstrual migraine
Anne MacGregor discusses her recent Review of menstrual migraine, and explains why the problem needs greater recognition.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(20)30482-8/fulltext
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch
Peter Rothwell on asymptomatic carotid stenosis and stroke
Peter Rothwell (Oxford University) discusses his research, found in our new issue, on asymptomatic carotid stenosis and stroke.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(20)30484-1/fulltext
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the
Spinal cord injury and degenerative cervical myelopathy
Professor Michael Fehlings discusses the implications of his two papers in the Jan 2021 issue of The Lancet Neurology.
Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(20)30407-5/fulltext
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch of
Genetic risk factors for sCJD
Emma Jones and Simon Mead discuss their article in The Lancet Neurology, identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch of, The Lancet Medical Imaging and Theranostics.
You can visi
Prednisone in short-term prevention of cluster headache
Mark Obermann discusses his study examining the use of prednisone for the short-term prevention of cluster headache.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch of, The Lancet Medical Imaging and Theranostics.
You can visit https://www.thelancet.com/medical-imaging-theran
PET imaging of inflammation in neurological and psychiatric disorders
Robert Innis discusses his work on measuring neuroinflammation using PET imaging.
Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch of, The Lancet Medical Imaging and Theranostics.
You can visit https://www.thelancet.com/medical-imaging-theranostics to learn more.
Continue this
Recommended
The Healing Childhood Trauma Podcast
The Documentary Podcast
The Rest Is Money
Newscast
Easy English: Learn English with everyday conversations
Learning English from the News
Who We Are Now with Izzy & Richard Hammond
Uk Mix RadioShow
CAA on General Aviation
Pod Save The King
Pride and Prejudice (version 6, dramatic reading)
InsideAIR
